The effect of docarpamine, a dopamine pro-drug, on blood pressure and catecholamine levels in spontaneously hypertensive rats

Clinical and Experimental Hypertension

Volumn 22, Issue 4, 2000, Pages 419-429

  Sanada, Hironobu ^a   Asico, Laureano D ^b   Shigetomi, Shuichi ^d   Tanaka, Kiyonobu ^d   Niimura, Susumu ^d   Watanabe, Hidetsuna ^d   Goldstein, David S ^c   Felder, Robin A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d NONE

Author keywords

adrenergic receptor; Dopamine pro drug; Vasopressin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ARGIPRESSIN[1 (3,3 CYCLOPENTAMETHYLENE 3 MERCAPTOPROPIONIC ACID) 2 (O METHYLTYROSINE)]; CATECHOLAMINE; DOCARPAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; PHENTOLAMINE; PHENYLEPHRINE; PRODRUG; VASOPRESSIN ANTAGONIST; VASOPRESSIN V1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BOLUS INJECTION; CATECHOLAMINE BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; CATECHOLAMINES; CATECHOLS; DOPAMINE; DOPAMINE ANTAGONISTS; HORMONE ANTAGONISTS; HYPERTENSION; MALE; PHENTOLAMINE; PRODRUGS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, DOPAMINE D1; RECEPTORS, VASOPRESSIN;

EID: 0034116476     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-100100081     Document Type: Conference Paper

References (36)

1. Yamaguchi, I., Nishiyama, S., Akimoto, Y., Yoshikawa, M., Nakajima, H. A novel orally active dopamine prodrug TA-870. I. Renal and cardiovascular effects and plasma levels of free dopamine in dogs and rats. J Cardiovasc Phamacol. 1989; 13: 879-886.
2. Nishiyama, S., Yamaguchi, I., Akimoto, Y., Yoshikawa, M., Nakajima. H. A novel orally active dopamine prodrug TA-870. II. Evidence that TA-870 is a dopamine prodrug. J Cardiovasc Phamacol. 1989; 14: 175-183.
3. 2 dopamine receptor selective antagonists. J Cardiovasc Phamacol. 1989; 17: 560-567.
4. Nishiyama, S., Yamaguchi, I. A novel orally active dopamine prodrug TA-870. V. Natriuretic and positive inotropic effects in rats: An assessment after chronic administration. J Cardiovasc Pharmacol. 1991; 17: 768-777.
5. Jose, P.A., Eisner, G.M., Felder, R.A. The renal dopamine receptors in health and disease. Pharmacol Ther. 1998; 80: 149-182.
6. Fildes, R.D., Eisner, G.M., Calcagno, P.L., Jose, P.A. Renal α-adrenoceptors and excretion in the dog. Am J Physiol. 1985; 248: F128-F133.
7. Cornish, L., van den Buuse, M. Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin. Brain Res. 1995; 701: 28-38.
8. Bealer, S.L., Abell, S.O. Paraventricular nucleus histamine increases blood pressure by adrenoceptor stimulation of vasopressin release. Am J Physiol. 1995; 269: H80-H85.
9. Hegde, S.S., Jadhav, A.L., Lokhandwala, M.F. Role of kidney dopamine in the natriuretic response to volume expansion in rats. Hypertension. 1989; 13: 828-834.
10. 1 receptor-mediated natriuresis in the rat: in vivo and in vitro correlations. Am J Physiol. 1992; 263: R631-R638.
11. Szemeredi, K., Komoly, S., Kopin, I.J., Bagdy, G., Keiser, H.R., Goldstein, D.S. Simultaneous measurement of plasma and brain extracellular fluid concentrations of catechols after yohimbine administration in rats. Brain Res. 1991; 542: 8-14.
12. Pellevoisin, C., Chalon, S., Kung, H.F., Besnard, J.C., Guilloteau, D. Is TISCH a suitable tracer for in vivo study of modifications of the dopamine D-1 receptor? Nucl. Med. Biol. 1996; 23: 75-78.
13. Malpas, S.C., Coote, J.H. Role of vasopressin in sympathetic response to paraventricular nucleus stimulation in anesthetized rats. Am J Physiol. 1994; 266: R228-R336.
14. Riphagen, C.L., Pittman, Q.J. Mechanisms underlying the cardiovascular responses to intrathecal vasopressin administration in rats. Can J Physiol Pharmacol. 1989; 67: 269-275.
15. Berecek, K.H., Mitchum, T.N. Role of vasopressin in the cardiovascular response to stimulation of the locus coeruleus. Endocrinology. 1986; 118: 1829-1834.
16. Wells, T., Forsling, M.L. Aminergic control of vasopressin secretion in the conscious rat. J Physiol Pharmacol. 1992; 43: 59-64.
17. Brooks, D.P., Share, L., Crofton, J.T. Central adrenergic control of vasopressin release. Neuroendocrinology. 1986; 42: 416-420.
18. Rossi, N.F. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro. Am J Physiol. 1998; 275: E687-E693.
19. 1 agonist in dispersed hypothalamic cultures. Am J Physiol. 1996; 270: R404-R412.
20. 2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats. J Pharmacol Exp Ther. 1987; 242: 143-151.
21. Racke, K., Meuresch, J., Trapp, B., Muscholl, E. Modulation by fenoldopam (SKF82526) and bromocriptine of the electrically evoked release of vasopressin from the rat neurohypophysis. Effects of dopamine depletion. Naunyn Schmiedeberg's Arch Pharamcol. 1986; 332: 332-337.
22. Rivkees, S.A., Lachowicz, J.E. Functional D1 and D5 dopamine receptors are expressed in the suprachiasmatic, supraoptic, and paraventricular nuclei of primates. Synapse. 1997; 26: 1-10.
23. Defagot, M.C., Malchiodi, E.L., Villar, M.J., Antonelli, M.C. Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies. Brain Res Mol Brain Res. 1997; 45: 1-12.
24. Rohmeiss, P., Becker, H., Dietrich, R., Luft, F., Unger, T. Vasopressin: mechanism of central cardiovascular action in conscious rats. J Cardiovasc Pharmacol. 1986; 8: 689-696.
25. Hegarty, A.A., Felder, R.B. Vasopressin and V1-receptor antagonists modulate the activity of NTS neurons receiving baroreceptor input. Am. J. Physiol. 1997; R143-R152.
26. Seeman, P.L. in Receptor Tables. Vol 2: Drug Dissociation Constants for Neuroreceptors and Transporters. SZ Research, Toronto, Canada, 1993.
27. Grazzini, E., Boccara, G., Joubert, D., Trueba, M., Durroux, T., Guillon, G., Gallo-Payet, N., Chouinard, L., Payet, M.D., Serradeil Le Gal, C. Vasopressin regulates adrenal functions by acting through different vasopressin receptor subtypes. Adv Exp Med Biol. 1998; 449: 325-334.
28. Dahmer, M.K., Senogles, S.E. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors. J Neurochem. 1996; 66: 222-332.
29. Szmigielska, H., Szmigielski, A., Szadowska, A. The responsiveness of D1- and D2-dopamine receptors in the striatum and hypothalamus of spontaneous and vasopressin hypertensive rats. Pol J Pharmacol Pharm. 1992; 44: 355-364.
30. O'Connell, D.P., Ragsdale, N.V., Boyd, D.G., Felder, R.A., Carey, R.M. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension. 1997; 29: 115-122.
31. Mierau, J., Schneider, F.J., Ensinger, H.A., Chio, C.L., Lajiness, M.E., Huff, R. Pramipexole binding and activation of clone and expressed D2, D3 and D4 receptors. Eur J Pharmacol. 1995; 290: 29-36.
32. Kaneko, S., Eisner, G.M., Jose, P.A. Effect of pramipexole, a dopamine-1/dopamine-2 receptor agonist, on sodium excretion and blood pressure in spontaneously hypertensive rats. J Auton Pharmacol. 1990; 10 [Suppl 1] s53-s60.
33. Sengupta, S., Lokhandwala, M.F. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats. J Auton Pharmacol. 1985; 5: 289-294.
34. Lefevre-Borg, F., Lorrain, J., Lechaire, J., Thiry, C., Hicks, P.E., Cavero, I. Studies on the mechanisms of the development of tolerance to the hypotensive effects of fenoldopam in rats. J Cardiovasc Pharmacol. 1988; 11: 444-455.
35. McCoy, C.E., Douglas, F.L., Goldberg, L.I. Selective antagonism of the hypotensive effects of dopamine in spontaneously hypertensive rats. Hypertension. 1986; 8: 298-302.
36. Linthorst, A.C., Broekhoven, M.H., De Jong, W., Van Wimersma Greidanus, T.B., Versteeg, D.H. Effect of SCH 23390 and quinpirole on novelty-induced grooming behaviour in spontaneously hypertensive rats and Wistar-Kyoto rats. Eur J Pharmacol. 1992; 219: 23-28.